- view as grid
- view as list
In this Wall Street Journal Think Tank column, Drew Altman looks at the debate about increases in Obamacare premiums and public misperceptions about who is and is not affected by them.
Donor government funding to support HIV efforts in low- and middle-income countries fell for the first time in five years in 2015, decreasing from US$8.6 billion in 2014 to US$7.5 billion, finds a new report from the Kaiser Family Foundation and the Joint United Nations Programme on HIV/AIDS (UNAIDS) released in…
Financing the Response to HIV in Low- and Middle-Income Countries: International Assistance from Donor Governments in 2015
This report, Financing the Response to AIDS in Low- and Middle-Income Countries: International Assistance from Donor Governments in 2015, tracks funding levels of the donor governments that collectively provide the bulk of international assistance for AIDS through bilateral programs and contributions to the Global Fund to Fight AIDS, Tuberculosis and Malaria. Donor government funding to support HIV efforts in low- and middle-income countries fell for the first time in five years in 2015, decreasing from US$8.6 billion in 2014 to US$7.5 billion.
Using Medicaid State Drug Utilization Data, this brief presents the 50 most costly drugs before rebates used by the Medicaid program over the January 2014 through June 2015 period. It then examines reasons why these drugs are so costly; explores case studies on opioids, hepatitis C drugs, and the drug Abilify; and considers policy implications.
Costly specialty drugs, such as those used to treat Hepatitis C and HIV, are among the most costly medications in state Medicaid programs, chiefly because of their high prices for a course of treatment, according to a new Kaiser Family Foundation analysis of Medicaid’s most costly outpatient drugs. Abilify, an…
Most Americans Worry about Large Number of Zika Cases in U.S. Over Next Year While the public tilts narrowly toward unfavorable views of the Affordable Care Act, presumptive Democratic nominee Hillary Clinton holds a clear advantage on health care issues over presumptive Republican nominee Donald Trump as the 2016 national…